Clinical Trial Update: A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge) [Phase 3]

View source ↗

Summary

MM120's Phase 3 trial for major depressive disorder is currently active but not recruiting. The trial is sponsored by Definium Therapeutics US, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• MM120

Snippet

Sponsor: Definium Therapeutics US, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: ACTIVE_NOT_RECRUITING